TNFRSF14 and cervical carcinoma: In our study, we identified four immune inhibitory checkpoint molecules (PD-1, HVEM, LAG-3, and TIM-3) and two immune co-stimulatory checkpoint molecules (CD27 and CD40) to be significantly elevated in CVL collected from patients with cervical cancer compared with healthy women or women with precancerous dysplasia.